Oprelvekin "not worth the cost" for thrombocytopenia prophylaxis

By  

Inpharma, Vol. 1, Iss. 1397, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Treatment of heparin-induced thrombocytopenia in cardiovascular patients

By Matthai William H  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 3, 2006-02 ,pp. : 267-276

Informa Healthcare

Access to resources Recommend Favorite

Drugs for the Prevention and Treatment of Thrombosis in Patients with Heparin-Induced Thrombocytopenia

By Lubenow N.   Greinacher A.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 429-443

Adis International

Access to resources Recommend Favorite

Thrombocytopenia Associated with Antithrombotic Therapy in Patients with Cardiovascular Diseases: Diagnosis and Treatment

By Burcak Kilickiran Avci  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 5, 2008-01 ,pp. : 327-339

Adis International

Access to resources Recommend Favorite

Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders

By Pathak Swati   Roth Michael   Verma Amit   Steidl Ulrich  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1667-1675

Informa Healthcare

Access to resources Recommend Favorite